⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
COCP News
Cocrystal Pharma, Inc. Common Stock
Form 8-K
sec.gov
COCP
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
globenewswire.com
COCP
OPK
Form 8-K
sec.gov
COCP
Form 8-K
sec.gov
COCP
Form 8-K
sec.gov
COCP